01 9Ibrance
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 4,961
2018 Revenue in Millions : 4,118
Growth (%) : 20
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 5,392
2019 Revenue in Millions : 4,961
Growth (%) : 9
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 5,437
2020 Revenue in Millions : 5,392
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 5,120
2021 Revenue in Millions : 5,437
Growth (%) : -6
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 4,753
2022 Revenue in Millions : 5,120
Growth (%) : -7
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 723
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 2,135
2015 Revenue in Millions : 723
Growth (%) : 195
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 3,126
2016 Revenue in Millions : 2,136
Growth (%) : 46
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 4,118
2017 Revenue in Millions : 3,126
Growth (%) : 32%
LOOKING FOR A SUPPLIER?